hazop
DESCRIPTION
Hazop TrainingTRANSCRIPT
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 1/75
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 2/75
Cadila Pharmaceuticals
Limited 2
HAZOP STUDY
• Hazard and Operability study
• Look for potential hazards
• Discover operational problems
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 3/75
Cadila Pharmaceuticals
Limited 3
BEFORE A HAZOP: THE QUESTIONS
• When should the HAZOP be carried out
• What should be HAZOPed
• Who is re!uired
• What information is re!uired
• What preparation is re!uired to help the HAZOP "o
smoothly
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 4/75
Cadila Pharmaceuticals
Limited 4
WHEN?
NEW PROCESS/PLANT
Once ne# process$plant desi"n is %frozen&'
Pipin" ( )nstrumentation Dia"rams *P()Ds+ are fi,ed
Process route has been chosen
Operatin" instructions are prepared
-asis of safety in place.
• /ot too late'
0 easier to chan"e paper#ork than metal#ork
0 costs of re1schedulin" a pro2ect.
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 5/75
Cadila Pharmaceuticals
Limited 5
WHEN?
EXISTING PROCESS/PLANT
3o prescribed schedule
Once follo#in" up to date'
Pipin" ( )nstrumentation Dia"rams *P()Ds+
Operatin" procedures
Pre1meetin" may be re!uired to ensure everythin" is
up to date beforehand.
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 6/75
Cadila Pharmaceuticals
Limited 66
MANAGING A HAZOP STUDY
1. Def!e "#e $%&'e (!)&*+e%",e$ &f "#e $"-)
4. Appoint a team leaderand select the team
5. 6onduct HAZOP
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 7/75
Cadila Pharmaceuticals
Limited 7
WHAT TO HAZOP?
SCOPE OF HAZOP STUDY
What is ne# and #hat is e,istin"7ay only #ant to cover the ne# parts
Are parts of the process repeats of previous
processes6ould use a checklist or other techni!ue on repeat plant
What are the natural boundary limits of the
plant
6han"e of responsibility-ulk stora"e or container char"in"$dischar"in"
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 8/75
Cadila Pharmaceuticals
Limited 8
WHAT TO HAZOP?
Do #e cover utilities $ services $ vent systems
All can be affected by a process8 even if plant is e,istin". )s it a ne# or revised process in e,istin"
plant$e!uipmentHAZOP is re!uired but look at effects of chan"es only.
Are additional revie#s re!uiredPressure relief.
Plant layout.
6omputer control system.
9eneral safety$adherence to re"ulation etc.
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 9/75
Cadila Pharmaceuticals
Limited 99
MANAGING A HAZOP STUDY
:. Define the scope andob2ectives of the study
. A''&!" ( "e(0 e()e2(!) $ee%" "#e "e(0
5. 6onduct HAZOP
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 10/75
Cadila Pharmaceuticals
Limited 10
WHO IS REQUIRED?
MA3E UP OF HAZOP TEAMS
NEW PROCESS/PLANT DESIGN
)ndependent chairman$secretary Pro2ect en"ineer Process en"ineer ;H< e,pert )nstrumentation en"ineer *if hi"hly
instrumented plant+ 6ommissionin" or plant mana"er =esearch chemist
;,perience important
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 11/75
Cadila Pharmaceuticals
Limited 11
WHO IS REQUIRED?
MA3E UP OF HAZOP TEAMSEXISTING PLANT 4REPEAT HAZOP5 NEW PROCESS OR
MODIFICATION6
•)ndependent chairman$secretary•Plant mana"er *production back"round+•Process foreman or operator *practical e,perience+•Plant maintenance en"ineer *mechanical back"round+
•)nstrument en"ineer *if hi"hly instrumented process+•Process en"ineer•<H; e,pert•Process chemist•E7'e2e!%e 0'&2"(!"
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 12/75
Cadila Pharmaceuticals
Limited 12
WHAT INFORMATION?
3EY DOCUMENTS
Process ( )nstrumentation Dia"rams *P()Ds+1 )mportant for all studies
-asis of study on continuous plant
Operatin" )nstructions *batch sheets8 recipes etc.+ -asis for batch process HAZOPs
Also for batch operations in continuous plants e.". chan"in" filters
Also for start1up$shutdo#n8 maintenance operations etc.
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 13/75
Cadila Pharmaceuticals
Limited 13
WHAT INFORMATION?
OTHER IMPORTANT DOCUMENTS
<e!uence and )nterlock )nformation *computer controlled plants+
>unctional Desi"n <pecifications
6ause and effect charts
Process >lo#charts
7ass and heat balances
9eneral Arran"ement ( ;levation Dra#in"s
Plant layouts
=esearch and Development reports
?essel specifications ( mechanical dra#in"s
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 14/75
Cadila Pharmaceuticals
Limited 14
WHAT INFORMATION?
HAZARD DATA
• Process Hazard Data 0 7aterial hazard data
0 =esults of flammability and thermochemical testin"
Previous hazard study reports
-asis of safety and risk assessment studies
Operation8 i.e. fire and e,plosion
=eaction
)ncident reports
<ame or similar plants and$or processes
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 15/75
Cadila Pharmaceuticals
Limited 15
WHAT OTHER PREPARATION?
• Process should be divided into steps8 each #ith a)ef!e) )e$8! !"e!"'
0 ;,amples
• 3ransfer A from vessel @ to vessel
• Heat up vessel to BC6 over 5C minutes• ;,amine the P()D for continuous process
• 3hese distinct steps are called N&)e$
• T#$ $ )&!e * S"-) Le()e2.
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 16/75
Cadila Pharmaceuticals
Limited 16
DEFINITION OF NODES
• )mpossible to simultaneously analyse all possible deviations
of a process8 so it is subdivided into nodes *mana"eable
units+
• /o clear and uni!ue methodolo"y to define the nodes that
subdivide the system under study
• =ules for /odes' 0 <hould cover the entire facility.
0 7ust have continuity bet#een plant sections and
operations
0 S#&-) #(,e ( $'e%f% )e$8! !"e!"&!
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 17/75
Cadila Pharmaceuticals
Limited 17
WHAT PREPARATION?
TYPICAL NODES
/odes can be'
Lines ?essels Plant sections Process steps
if doin" start1up$shutdo#n or batch process
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 18/75
Cadila Pharmaceuticals
Limited 1818
NODES
B("%# ,$. C&!"!-&-$
C&!"!-&-$ '2&%e$$'
•Plant element
0 Pump
0 =eactor
0 ;,chan"er
0 6olumn
•Line *pipin"
• B("%# '2&%e$$:
0 <tep of operatin" procedure
0 3ransitory operation *start8
stop8 samplin"+
0 <pecial operation
*maintenance8 cleanin"8 ...
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 19/75
Cadila Pharmaceuticals
Limited 19
NODES AND BATCH OPERATING
INSTRUCTIONS
Operatin" steps sometimes need to be sub1divided
<tep : can be sub1divided into 5 nodes
<3;P/o
OP;=A3)O/ P=;6AE3)O/< <)9/
:B)nstall drum of reactant -
in char"in" bay;nsure drum is
earthed
:D3ransfer BB l of - to
char"in" vessel ?:C:usin" vacuum
Wear full protectiveclothin" and
"o""les
:F6har"e reactor =:C: #ithBB l of - over :B minutes
7anually controlvalve :C:
STEPNo
OPERATION
16a Establish nitrogn blan!t on "r#$ %nt
16b Establish %a&##$ on '101 &harging %ssl
16& Trans(r 55 l o( ) to &harging %ssl '101
9MIXED NODES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 20/75
Cadila Pharmaceuticals
Limited 20
9MIXED NODES
• 6an have P()D and operatin" procedures based
nodes to"ether
• 7anual operations on continuous plant
0 >ilter chan"es
• -atch operations involvin" comple, plant 0 -atch distillations can be split into'
• Heatin" system
• ?apour line throu"h condenser
• 6ondensate line
NODES EXAMPLE
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 21/75
Cadila Pharmaceuticals
Limited 21
NODES EXAMPLE
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 22/75
Cadila Pharmaceuticals
Limited 2222
SIMPLE EXERCISE
MA3ING INSTANT COFFEE
• /odes' 0 -rin" out cup$mu"
0 >ill kettle
0 -oil kettle
0 6har"e 6offee to cup
0 >ill #ith cup #ith boilin" #ater
0 Add milk and su"ar *optional+
0 <tir
0 3ransfer to place of use.
OTHER STATUS GRIDS
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 23/75
Cadila Pharmaceuticals
Limited 23
OTHER STATUS GRIDS
3akes considerable advance preparation time
/eed to "et a balance a"ainst level of detail re!uired
S"e'N&.
P2&%e$$S"e'
A8"("&2 B&""&0;(1,e
;e!";(1,e
<(%=e"H&" W("e2
: ?erify=eactor6lean and;mpty
Off 6losed Open Off
4 6har"e A Off 6losed Open Off
5 6har"e - Off 6losed Open Off
G <tart A"itator
On 6losed 6losed Off
B Heat1up toCI6
On 6losed 6losed On 16ontrolledby D6<
DRAINS ;ENTS AND
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 24/75
Cadila Pharmaceuticals
Limited 24
DRAINS5 ;ENTS AND
INTERCONNECTED PLANT
• 7ay need to look at interactions in drains8 vents
and relief systems'
0 Often connected to various plants.
0 )nterface bet#een a number of P()Ds 0 >luid incompatibilities
0 <imultaneous releases
0 Possible chokes8 causin" backflo#
MANAGING A HAZOP STUDY
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 25/75
Cadila Pharmaceuticals
Limited 2525
MANAGING A HAZOP STUDY
:. Define the scope andob2ectives of the study
. A''&!" ( "e(0 e()e2(!) $ee%" "#e "e(0
5. 6onduct HAZOP
HAZOP APPROACH
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 26/75
Cadila Pharmaceuticals
Limited 26
HAZOP APPROACH
Define )ntended Process
=epeat
Action6ause 6onse!uence <afe"uard
P(2(0e"e2
G-)e W&2)>
De,("&!
J
EXAMPLE
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 27/75
Cadila Pharmaceuticals
Limited 27
EXAMPLE
DE;IATIONS
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 28/75
Cadila Pharmaceuticals
Limited 28
DE;IATIONS
• Deviation from D;<)9/ )/3;/3 0 )f variation is e,pected *e.". operatin" process #ithin
temperature ran"e+8 then deviations outside this %envelope&
should be considered
• Deviations are often from measurable parameter
that can be controlled' 0 >lo# 0 3emperature 0 Pressure
• Deviation J "uide#ord K parameter
GUIDE WORDS
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 29/75
Cadila Pharmaceuticals
Limited 29
GUIDE WORDS
O"#e2 "#(!
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 30/75
Cadila Pharmaceuticals
Limited 3030
O"#e2 "#(!
• <tart up$ <hut do#n
• <pilla"e
• <amplin"8 <tora"e etc..
• Waste Disposal
• >ire >i"htin"
• >irst Aid
• 7aterials of construction
• /oise• Labellin" 1 Pipe#ork etc..
• 7aintenance
• <tatic
• Liftin" and Handlin"
• Dischar"es to Atmosphere• ?acuum =elief
• ;,plosion =elief
• ;ffluent <treams 1 7i,in"
• <pares• 3rainin"
• <pecial 3ools
• 6leanin"
• >oamin"
COMMON PARAMETERS
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 31/75
Cadila Pharmaceuticals
Limited 3131
COMMON PARAMETERS
*lo+,#antit-T$.rat#rPrss#r
/%lon&ntrationo$.ositionnsit-'is&osit-
Ra&tion Agitation at Trans(r S.aration
Ti$ S#n& Or"r onta$ination orrosion
HAZOP GUIDEWORDS FOR PIPE FLOW
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 32/75
Cadila Pharmaceuticals
Limited 32
HAZOP GUIDEWORDS FOR PIPE FLOW
G-)e ?&2) De,("&!
/one /o flo#
7ore of Hi"h flo#
Less of Lo# flo#
=everse -ack flo#
Part of Wron"concentration
As #ell as 6ontamination
Other than Wron" material7isdirected
IN;ALID GUIDE WORDS /PARAMETER
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 33/75
Cadila Pharmaceuticals
Limited 33
IN;ALID GUIDE WORDS /PARAMETER
COMBINATIONS
• Other than K temperature
• /o K temperature *unless at 14F5.:BI6+
• =everse K time• Part of K pressure
DE;IATION EXAMPLE
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 34/75
Cadila Pharmaceuticals
Limited 34
O.rating&on"itions
L
/%l
O.ti$al st.oint
O.rating&on"itions
Ti$
Deviation+ith rs.&tto th intnt
SIMPLE EXERCISE
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 35/75
Cadila Pharmaceuticals
Limited 3535
SIMPLE EXERCISE
MA3ING INSTANT TEA
• >)LL)/9 6EP W)3H WA3;=
• Appropriate deviations 0 /o flo# 0 7ore flo# 0 As #ell as flo# 0 Other than flo# 0 7ore level
0 Less temperature 0 Other than composition 0 6ontamination
Other deviations are unlikely orinappropriate e.". morepressure.
HAZOP APPROACH
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 36/75
Cadila Pharmaceuticals
Limited 36
HAZOP APPROACH
Define )ntended Process
=epeat
ActionC(-$e 6onse!uence <afe"uard
Parameter
9uide Word>
Deviation
J
CAUSES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 37/75
Cadila Pharmaceuticals
Limited 37
• 3he reasons for the deviation 0 e.". 6auses for no flo# of solvent to vessel
• Pump failed
• ?alve*s+ closed
• -locka"e
• /o material char"ed.
• 6an be associated #ith the node in !uestion8 but
also can be before or after it.
CAUSES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 38/75
Cadila Pharmaceuticals
Limited 38
GUIDELINES
• -e as clear as possible e.". used 3A9 numbers
• 7ay need to */ot necessary+ 0 split do#n further8 if conse!uences are different 0 "roup to"ether e.". if conse!uences are trivial.
• /ot normally considered as causes' 0 3#o independent faults *e,cept t#o human error or t#o
failures #ith severe conse!uences+. 0 >ailures of safety devices *relief valves8 rupture disks8 safety
shutdo#n systems+.
OTHER TYPICAL CAUSES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 39/75
Cadila Pharmaceuticals
Limited 39
0 Human error
0 ;!uipment failure
0 Obstruction
0 6orrosion 0 >ailure8 leak
0 <torm8 frost8 sun8 fire
SIMPLE EXERCISE
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 40/75
Cadila Pharmaceuticals
Limited 4040
SIMPLE EXERCISE
MA3ING INSTANT TEA
• >)LL)/9 6EP W)3H WA3;=
• Appropriate causes for 7ore
Level
0 Human error
0 Hi"h flo#
0 6ontrol failure *6offee
machine+
HAZOP APPROACH
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 41/75
Cadila Pharmaceuticals
Limited 41
Define )ntended Process
=epeat
Action6ause C&!$e@-e!%e <afe"uard
Parameter
9uide Word>
Deviation
J
CONSEQUENCES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 42/75
Cadila Pharmaceuticals
Limited 42
• 6onse!uence of deviation 0 ;.". Possible conse!uences of no flo# of solvent to vessel
• Pump cavitation
• Line failure due to over1pressurisation1 spilla"e of solvent leadin" to possiblefire
• =una#ay reaction *if solvent is diluents+
• <hould state ultimate hazard e.". fire8 to,ic e,posure etc.
• <hould NOT take into account active safe"uards 0 =e!uirin" action
• <hould be listed for each cause.
CONSEQUENCES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 43/75
Cadila Pharmaceuticals
Limited 43
GUIDELINES
• One cause may have multiple conse!uences. >or e,ample8 a
an open drain on a methanol pump could lead to' 0 Pool fire 0 3o,ic cloud dispersion. 0 >lammable cloud e,plosion. 0 Dischar"e into public #ater#ays. 0 Loss of production
• Once a"ain8 be precise
• List EL3)7A3; conse!uences re"ardless of safe"uards. 0 6an take account of passive safe"uards such as #alls
• <hould be listed a"ainst each cause
CONSEQUENCES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 44/75
Cadila Pharmaceuticals
Limited 44
GUIDELINES
• >ollo# the !uestion M<o WhatM
• 6onsider the plant layout and the distribution of staff in it.
• 6onsider the conse!uences on the node in !uestion8 but also
before and after it.• Discard those conse!uences #hose probability of
occurrence is very lo# e.". #here there are passive
safe"uards.
CONSEQUENCES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 45/75
Cadila Pharmaceuticals
Limited 45
• ;ffects intensity' physical out#ard si"n of the event ' – Overpressure – 3hermal flu, – Atmospheric spreadin" of to,ic or flammable "as – Described "(=!8 !"& (%%&-!" '($$,e $(fe8-(2)$ *6ertain
functionin" ' pressure resistance8 retention pit *e.". #aterproof +8
fire#all8 ...+
• Dama"es impacts on tar"ets *7an8 environment8 facilities+• -urn• Lethal effects• Pollution *land8 #ater8 air+• >acility destruction
CONSEQUENCES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 46/75
Cadila Pharmaceuticals
Limited 46
EXAMPLE
• Possible conse!uences of no flo# of flammable solventto vessel
• Pump cavitations8 causin" pump dama"e and possible fire
• Line failure due to over1pressurisation8 leadin" to spilla"e of
solvent leadin" to possible fire• As above for pipe rupture
• =una#ay reaction *if solvent is diluents+
SIMPLE EXERCISE
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 47/75
Cadila Pharmaceuticals
Limited 4747
MA3ING INSTANT TEA
>)LL)/9 6EP W)3H WA3;=
• Appropriate conse!uences for
7ore Level 0 <pilla"e of boilin" #ater$3;A 0 Possible scaldin" of
6offeemaker.
HAZOP APPROACH
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 48/75
Cadila Pharmaceuticals
Limited 48
(in Intn"" Pro&ss
R.at
A&tiona#s ons#n& SafeguardPara$tr
#i" or"
+
%iation
SAFEGUARDS
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 49/75
Cadila Pharmaceuticals
Limited 49
• Any measure that prevents the occurrence of
an accident or limit the escalation of events
that arise as a result of it.
• >or each deviation8 safe"uards can either' 0 Prevent or control causes 0 7iti"ate conse!uences
• 6an be several or even none
• 6an be either hard#are or soft#are
0 Procedures can be a safe"uard
SAFEGUARDS
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 50/75
Cadila Pharmaceuticals
Limited 50
6an be'•Passive
0 static devices
0 ;.". a bund or fire la""in"
• Active 0 dynamic devices re!uire an e,ternal input
0 ;.". <afety trip
SAFEGUARDS
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 51/75
Cadila Pharmaceuticals
Limited 51
• -y takin" into account preventive and protective independent safe"uards8 the
risk is reduced
•
3he fre!uency of an undesirable event is lo#ered
– Accordin" to the number of '2e,e!",e $(fe8-(2)$ and their
effectiveness
• 3he severity of the conse!uences is lo#ered
– Accordin" to the number of '2&"e%",e $(fe8-(2)$8 their action
and their effectiveness
PRE;ENTATI;E SAFEGUARDS
EXAMPLES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 52/75
Cadila Pharmaceuticals
Limited 52
EXAMPLES
• Procedural safe"uards ' 0 Written procedures aimed at verifyin" the implementation of certain
actions8 N 0 ;,ample ' vacuum ti"htness test before each operation
• Human safe"uards' 0 An operator action is needed
• 7aterial safe"uards' 0 )ndependent from the operator 0 6ontrol system 0 )nstrumental safety chains 0 ?ent device
PROTECTI;E SAFEGUARDS
EXAMPLES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 53/75
Cadila Pharmaceuticals
Limited 53
EXAMPLES
• ;ye <ho#er1<pray and safety sho#ers
• Leak detection and #ater curtains
• Alarm and buildin" evacuation
• >ire fi"htin" response• uick closin" valve in case of leak
• ;,tin"uisher systems
• Personal protective e!uipment
SIMPLE EXERCISE
MA3ING INSTANT TEA
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 54/75
Cadila Pharmaceuticals
Limited 5454
MA3ING INSTANT TEA
• >)LL)/9 6EP W)3H WA3;=
• Appropriate safe"uards for 7ore
Level
0 3rainin"
0 <mall !uantity char"ed
*inherent safety+
0 Ese of saucer.
HAZOP APPROACH
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 55/75
Cadila Pharmaceuticals
Limited 55
(in Intn"" Pro&ss
R.at
Actiona#s ons#n& Sa(g#ar"
Para$tr
#i" or"
+
%iation
ACTIONS AND RECOMMENDATIONS
HAZOP OB<ECTI;E
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 56/75
Cadila Pharmaceuticals
Limited 56
HAZOP OB<ECTI;E
3he ob2ective of the HAZOP is the
)dentification
of Potential Hazards and
Operability Problems
)t isnot
the solution of those problems
Actions #ill be "enerated for subse!uent desi"n consideration
ACTIONS OR RECOMMENDATIONS
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 57/75
Cadila Pharmaceuticals
Limited 57
• <hould only be re!uired if a"reed safety or operability ob2ectives are not met
• 7ay call for hard#are or soft#are solutions
• 6an often state an ob2ective and not a specific re!uirement'
0 ;.". %Provide system to prevent vessel hi"h pressure&8
rather than %install vessel pressure trip that shuts inlet
valve&.
• 7ay ask for further consideration or investi"ation
0 Actions may therefore "enerate further actions or
recommendations 0 Hence revie#s may be re!uired.
ACTIONS OR RECOMMENDATIONS
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 58/75
Cadila Pharmaceuticals
Limited 58
• 6arefully consider #ordin"
A MrecommendationM may commit the company to a
*potentially costly+ course of action 3he team must be sure that this #as the intention
• )f necessary8 actions should be prioritised by the severity of the risk
0Priority to be assi"ned durin" the HAZOP meetin"8
and confirmed by the team leader after#ard
• Actions should be assi"ned #ith a timescale for implementation appropriate to the
priority.
SIMPLE EXERCISE
MA3ING INSTANT TEA
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 59/75
Cadila Pharmaceuticals
Limited 5959
MA3ING INSTANT TEA
• >)LL)/9 6EP W)3H WA3;=
• Appropriate recommendationsfor 7ore Level
0 3rainin" for 6offeemaker
0 )ncreased supervision
0 <pilla"e containment
HAZOP RECORDING
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 60/75
Cadila Pharmaceuticals
Limited 6060
T-.i&al +or!sht as (ollo+s
9PARAMETER FIRST APPROACH
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 61/75
Cadila Pharmaceuticals
Limited 6161
Define )ntended Process
=epeat
Action6ause 6onse!uence <afe"uard
Parameter
9uide Word
>
Deviation
J
• Often used in HAZOPs.• ;ach parameter considered in
turn
• Deviations8 #ith associated
causes8 conse!uences etc. listed
for each parameter
• Once all credible deviations
e,hausted for the parameter8
start on ne,t one.
NODE IS FINISHED
ADDITIONAL ISSUES TO CONSIDER
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 62/75
Cadila Pharmaceuticals
Limited 62
ADDITIONAL ISSUES TO CONSIDER
• >ailure of utilities *po#er8 air8 steam coolin" #ater etc.+
• >ailures and deviations associated #ith process control systems8 e.".PL6s. /.-. 7ore detailed study such as a 6HAZOP may be re!uired.
• Plant maintenance.• Pressure relief systems• 3estin" of alarms and trips• 9eneral #orkplace hazards such as hot surfaces8 machinery8 liftin" etc.
3#o points'• 6hecklists can be used to prompt discussion of additional issues• )ssues may be covered by separate assessments.
R$= ($$e$$0e!" ! HAZOP
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 63/75
Cadila Pharmaceuticals
Limited 63
RIS3 ASSESSMENT
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 64/75
Cadila Pharmaceuticals
Limited 64
HAZA=D )D;/3)>)6A3)O/
6an Hazard -e ;liminated6ost ;ffectively
6O/<;E;/6; A/AL<)<
6an 6onse!uences -e;liminated Or =educed
3o Acceptable Limits6ost ;ffectively
EA/3)>)6A3)O/ O> ;?;/3P=O-A-)L)3 A/D =)<
Does =isk 7eet A"reed 6riteria
;liminate Hazard
)mplement and=e1assess
7ake )mprovementsand =e1assess
3OL;=A-L; $ A66;P3A-L; A63)?)3
es /o
es/o
es/o
A:OP
HAZOP (!) 2$= ($$e$$0e!"
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 65/75
Cadila Pharmaceuticals
Limited 65
• HAZOP primarily a #((2) )e!"f%("&! tool
• 7ay need risk assessment to' 0 Define need for action$recommendation
0 Qustify need for action$recommendation
0 Qustify cost of action$recommendation
0 Assi"n priority action$recommendation
• R$= R(!=!8 4RR6 therefore increasin"ly used in HAZOP• == normally made A>3;= safe"uards taken into account
N&"&! &f R$=
=i k > f t it f
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 66/75
Cadila Pharmaceuticals
Limited 66
• =isk J >re!uency of event , severity of conse!uence
• >armer curve
N&"&! &f R$=
f f
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 67/75
Cadila Pharmaceuticals
Limited 67
• A level of risk can be reduced by lo#erin" the fre!uency
of an undesirable event and$or by miti"atin" the severity
R$= "&e2(*"/(%%e'"(*"
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 68/75
Cadila Pharmaceuticals
Limited 68
/eed to have criteria for #hether a risk is acceptable$tolerable or
not.
EFFECT OF SAFEGUARDS
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 69/75
Cadila Pharmaceuticals
Limited 69
• Preventative safe"uards reduce the fre!uency• Protective safe"uards miti"ate *reduce+ the conse!uences.
• 3#o cases have to be considered '
0 :+ 3he safe"uard #orks' Dama"es severity is lo#ered8
occurrence fre!uency remains unchan"ed
0 4+ 3he safe"uard does not #ork' <everity remains unchan"edbut this event fre!uency is lo#er than the startin" fre!uency
• Have a failure probability per demand
HAZOP RIS3 TOLERABILITY MATRICES
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 70/75
Cadila Pharmaceuticals
Limited 70
F&2 HAZOP !ee) ( $0'e2 ($ &f )ef!!8 "&e2(*"/(%%e'"(*"5 .e. 2$=
"&e2(*" 0("2%e$
A$& =!&! ($ 9R$= R(!=!8
• A McrudeM risk !uantification
• Eses !ualitative rather than !uantitative terms
• 6an be carried out before and$or after the preventative and protective
safe"uards are taken into account.
0 /.-. ) tend to prefer after only8 as the rankin" is often used to 2ustify
recommendations.
HAZOP RIS3 RAN3ING
A McrudeM risk !uantification
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 71/75
Cadila Pharmaceuticals
Limited 71
!
A 'Acceptable as desi"ned
6 'AcceptableR risk control measures alreadyspecified
/ '/ot DesirableR risk control measures to be
installed #ithin specified period
E 'EnacceptableR only acceptable if risk control
measures installed before operation
= '=e1desi"n re!uired
: 4 5 G B
: A A A 6 /
4 A A 6 6 /
5 A 6 6 / E
G 6 6 / E =
B 6 / E = =
6onse!uence
HAZOP RIS3 RAN3ING
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 72/75
Cadila Pharmaceuticals
Limited 7272
6onse!uence 6ate"ories >ire ;,plosion 3o,ic =elease ;nvironmental =elease Personnel =isk Production Loss
6apital Loss
Eseful for hazards rankin"8 buttime consumin"
>or operability8 cost $ benefit
principles may be used
<ites often develop their o#n
system
>re!uency 6onse!uence
: /ot e,pected durin" plantlifetime
/o $ 7inor effect
4
5
G
B 6ould occur on a re"ularbasis
7a2or catastrophe
RIS3 RAN3ING IN PHA PRO
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 73/75
Cadila Pharmaceuticals
Limited 73
• Se,e2"
0 : /o in2ury or health impacts 0 4 7inor in2ury or minor health impacts
0 5 )n2ury or moderate health impacts
0 G Death or severe in2ury
• L=e#&&)
0 : /ot e,pected to occur durin" facility life
0 4 6ould occur once durin" facility life
0 5 6ould occur several times durin" facility life
0 G 6ould occur on an annual basis *or more often+
• L=e#&&) $e,e2" 0-"'e) "&8e"#e2
RIS3 RAN3ING IN PHA PRO
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 74/75
Cadila Pharmaceuticals
Limited 74
7/21/2019 Hazop
http://slidepdf.com/reader/full/hazop-56da060ac8aa9 75/75
Cadila Pharmaceuticals
Limited 75
THAN3S